Palanas, Jane D.
HRN: 23-90-85 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/21/2023
10/27/2023
IVT
300mg
Q6
Skin Infection
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamSkin & Soft TissueUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes